Synjardy XR is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is Empagliflozin; Metformin Hydrochloride.
| Product ID | 0597-0290_2556e57c-d394-4693-b2e9-2b23921abd6b |
| NDC | 0597-0290 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Synjardy XR |
| Generic Name | Empagliflozin, Metformin Hydrochloride |
| Dosage Form | Tablet, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-12-10 |
| Marketing Category | NDA / NDA |
| Application Number | NDA208658 |
| Labeler Name | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Substance Name | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
| Active Ingredient Strength | 5 mg/1; mg/1 |
| Pharm Classes | Biguanide [EPC], Biguanides [CS], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2016-12-10 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA208658 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-12-10 |
| Marketing Category | NDA |
| Application Number | NDA208658 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-12-10 |
| Marketing Category | NDA |
| Application Number | NDA208658 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2016-12-10 |
| Ingredient | Strength |
|---|---|
| EMPAGLIFLOZIN | 5 mg/1 |
| SPL SET ID: | 8006ba29-ee3a-f852-a9bb-c8ec9b41cf66 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0597-0280 | Synjardy | empagliflozin, metformin hydrochloride |
| 0597-0290 | Synjardy | empagliflozin, metformin hydrochloride |
| 0597-0295 | Synjardy | empagliflozin, metformin hydrochloride |
| 0597-0300 | Synjardy | empagliflozin, metformin hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SYNJARDY 79145490 4590924 Live/Registered |
Boehringer Ingelheim International GmbH 2014-02-17 |